Anqi Zheng

5.1k total citations
26 papers, 309 citations indexed

About

Anqi Zheng is a scholar working on Infectious Diseases, Molecular Biology and Immunology. According to data from OpenAlex, Anqi Zheng has authored 26 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Anqi Zheng's work include SARS-CoV-2 and COVID-19 Research (13 papers), Immunotherapy and Immune Responses (5 papers) and COVID-19 Clinical Research Studies (4 papers). Anqi Zheng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (13 papers), Immunotherapy and Immune Responses (5 papers) and COVID-19 Clinical Research Studies (4 papers). Anqi Zheng collaborates with scholars based in China, Macao and Czechia. Anqi Zheng's co-authors include Qihui Wang, George F. Gao, Jianxun Qi, Xin Zhao, Zepeng Xu, Lili Wu, Kefang Liu, Pei Du, Shitong Qiao and Bin Bai and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Anqi Zheng

22 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anqi Zheng China 11 221 81 69 50 42 26 309
Pan-Pan Zhou China 8 252 1.1× 60 0.7× 91 1.3× 47 0.9× 45 1.1× 12 327
Linda Benincasa Italy 8 448 2.0× 74 0.9× 134 1.9× 59 1.2× 47 1.1× 14 496
Jin Zhu China 5 218 1.0× 91 1.1× 47 0.7× 52 1.0× 20 0.5× 12 349
Wenxu Jia China 5 207 0.9× 53 0.7× 84 1.2× 29 0.6× 42 1.0× 6 281
Mallorie E. Fouch United States 6 270 1.2× 51 0.6× 108 1.6× 58 1.2× 70 1.7× 7 374
Sven Blokland Netherlands 5 168 0.8× 30 0.4× 104 1.5× 29 0.6× 42 1.0× 8 247
Ikenna G. Madu United States 9 354 1.6× 142 1.8× 155 2.2× 45 0.9× 35 0.8× 10 492
Ariana Ghez Farrell United States 4 226 1.0× 41 0.5× 152 2.2× 26 0.5× 49 1.2× 4 304
Samitabh Chakraborti India 9 383 1.7× 131 1.6× 170 2.5× 47 0.9× 48 1.1× 18 582
Leah J. Homad United States 7 343 1.6× 76 0.9× 105 1.5× 79 1.6× 57 1.4× 9 417

Countries citing papers authored by Anqi Zheng

Since Specialization
Citations

This map shows the geographic impact of Anqi Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anqi Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anqi Zheng more than expected).

Fields of papers citing papers by Anqi Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anqi Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anqi Zheng. The network helps show where Anqi Zheng may publish in the future.

Co-authorship network of co-authors of Anqi Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Anqi Zheng. A scholar is included among the top collaborators of Anqi Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anqi Zheng. Anqi Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xueying, et al.. (2024). Nucleos(T)ide Analogue Treatment Has a More Pronounced Impact on Immune Repertoires of CHB Patients Compared to HCC Patients. Journal of Inflammation Research. Volume 17. 6229–6238.
2.
Sun, Shujuan, Ting Li, Anqi Zheng, et al.. (2024). Doctor-patient-family collaboration in community-based chronic disease management to enhance multidimensional value. Patient Education and Counseling. 132. 108604–108604. 3 indexed citations
3.
Luo, Yuwei, Anqi Zheng, Xin Wang, et al.. (2024). SARS-CoV-2 N protein-induced Dicer, XPO5, SRSF3, and hnRNPA3 downregulation causes pneumonia. Nature Communications. 15(1). 6964–6964.
4.
He, Qingwen, Yaling An, Xuemei Zhou, et al.. (2024). Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies. Med. 5(5). 401–413.e4. 11 indexed citations
5.
Yan, Rong, Anqi Zheng, Xueying Li, et al.. (2023). T cell receptor and B cell receptor exhibit unique signatures in tumor and adjacent non-tumor tissues of hepatocellular carcinoma. Frontiers in Immunology. 14. 1161417–1161417. 5 indexed citations
6.
Li, Xueying, Anqi Zheng, Baolin Liao, et al.. (2023). Assessing the chronic hepatitis B adaptive immune response by profiling specific T-cell receptor repertoire. Antiviral Research. 214. 105608–105608. 3 indexed citations
7.
He, Qingwen, Lili Wu, Zepeng Xu, et al.. (2023). An updated atlas of antibody evasion by SARS-CoV-2 Omicron sub-variants including BQ.1.1 and XBB. Cell Reports Medicine. 4(4). 100991–100991. 45 indexed citations
8.
Hu, Shixiong, Chunli Wu, Xinkai Wu, et al.. (2023). Classification of five SARS-CoV-2 serotypes based on RBD antigenicities. Science Bulletin. 68(23). 3003–3012. 17 indexed citations
9.
Wu, Lili, Anqi Zheng, Yan Chai, et al.. (2023). A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal delivery. Science China Life Sciences. 66(10). 2201–2213. 14 indexed citations
10.
Li, Linjie, Pu Han, Yufeng Xie, et al.. (2022). Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s. Cell Discovery. 8(1). 65–65. 38 indexed citations
11.
Xu, Zepeng, Pu Han, Pei Du, et al.. (2022). Binding and structural basis of equine ACE2 to RBDs from SARS-CoV, SARS-CoV-2 and related coronaviruses. Nature Communications. 13(1). 3547–3547. 19 indexed citations
12.
Hu, Yu, Kefang Liu, Pu Han, et al.. (2022). Host range and structural analysis of bat‐origin RshSTT182 /200 coronavirus binding to human ACE2 and its animal orthologs. The EMBO Journal. 42(4). e111737–e111737. 13 indexed citations
13.
Jia, Yunfei, Sheng Niu, Yu Hu, et al.. (2022). Cross-reaction of current available SARS-CoV-2 MAbs against the pangolin-origin coronavirus GX/P2V/2017. Cell Reports. 41(11). 111831–111831. 3 indexed citations
14.
Zhang, Di, Pu Han, Anqi Zheng, et al.. (2022). Structural basis of SARS-CoV-2 and its variants binding to intermediate horseshoe bat ACE2. International Journal of Biological Sciences. 18(12). 4658–4668. 13 indexed citations
15.
Zheng, Anqi, et al.. (2022). Examination of an extended sociocultural model of lifestyle physical activity among men and women. Current Psychology. 42(27). 23531–23540.
16.
Niu, Sheng, Jia Wang, Bin Bai, et al.. (2021). Molecular basis of cross‐species ACE2 interactions with SARS‐CoV‐2‐like viruses of pangolin origin. The EMBO Journal. 40(16). e107786–e107786. 43 indexed citations
17.
Li, Xueying, Rong Yan, Anqi Zheng, et al.. (2021). The dynamics and association of B and T cell receptor repertoires upon antibody response to hepatitis B vaccination in healthy adults. Human Vaccines & Immunotherapeutics. 17(9). 3203–3213. 5 indexed citations
18.
Wu, Hongkai, Baolin Liao, Xueying Li, et al.. (2021). Increased hepatitis B virus quasispecies diversity is correlated with liver fibrosis progression. Infection Genetics and Evolution. 93. 104938–104938. 1 indexed citations
19.
Zheng, Anqi. (2020). Implications of Novel Coronavirus Pneumonia on digital economy consumption and countermeasures. 46(2). 78. 1 indexed citations
20.
Joyce, Michael, Masaru Kanekiyo, Ling Xu, et al.. (2012). Outer Domain of HIV-1 gp120: Antigenic Optimization, Structural Malleability, and Crystal Structure with Antibody VRC-PG04. Journal of Virology. 87(4). 2294–2306. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pan-Pan Zhou Breakdown of academic impact, for papers by Linda Benincasa Breakdown of academic impact, for papers by Jin Zhu Breakdown of academic impact, for papers by Wenxu Jia Breakdown of academic impact, for papers by Mallorie E. Fouch Breakdown of academic impact, for papers by Sven Blokland Breakdown of academic impact, for papers by Ikenna G. Madu Breakdown of academic impact, for papers by Ariana Ghez Farrell Breakdown of academic impact, for papers by Samitabh Chakraborti Breakdown of academic impact, for papers by Leah J. Homad
Rankless by CCL
2026